Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis

British Journal of Clinical Pharmacology

Volumn 44, Issue 2, 1997, Pages 125-127

  Fu, L W ^a,b   Yang, L Y ^a,b   Chen, W P ^a   Lin, C Y ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cyclosporin A; Lupus nephritis; Neoral; Pharmacokinetics

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROEMULSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030852803     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00634.x     Document Type: Article

References (14)

1. Favre H, Miescher PA, Huang YP, et al. Ciclosporin in the treatment of lupus nephritis. Am J Nephrol 1990; 9(suppl 1): 57-60.
2. Puschett JB, Greenberg A, Holley J, et al. The spectrum of cyclosporin nephrotoxicity. Am J Nephrol 1990; 10: 296-309.
3. Awni WM. Pharmacodynamic monitoring of cyclosporin. Clinical Pharmacokinet 1992; 23: 428-448.
4. Drewe J, Meier R, Vonderscher J, et al. Enhancement of the oral absorption of cyclosporin in man. Br J Clin Pharmacol 1992; 34: 60-64.
5. Linholm A. Factors influencing the pharmacokinetics of cyclosporin in man. Ther Drug Monit 1991; 13: 465-477.
6. Linholm A, Kahan BD. Influence of cyclosporine pharmacokinetics,trough concentrations,and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54: 205-218.
7. Trull AK, Tan KKC, Uttridge J, et al. Cyclosporin absorption from microemulsion formulation. Lancet 1993; 341: 433.
8. Levy G, Grant D. Potential for CsA-Neoral in organ transplantation. Transplant Proc 1994; 25: 2932-2934.
9. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
10. Yang LY, Chen WP, Lin CY. Lupus nephritis in children - A review of 167 patients. Paediatrics 1994; 94: 335-340.
11. Garraffo R, Lapalus P. Simplified liquid chromatographic analysis for cyclosporine A in blood and plasma with use of rapid extraction. J Chromatogr 1985; 337: 416-422.
12. Lin CY, Lee SF. Comparison of pharmacokinetics between CsA capsules and Sandimmun Neoral in paediatric patients. Transplant Proc 1994; 26: 2973-2974.
13. Holt DW, Mueller EA, Kovarik JM, et al. Sandimmun Neoral pharmacokinetics: Impact of the New Oral Formulation. Transplant Proc 1995; 27: 1434-1437.
14. Fahr A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 1993; 24: 472-495.